Volume 9, Issue 1 (4-2019)                   JABS 2019, 9(1): 1187-1199 | Back to browse issues page

XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Fouman Ajirloo P, zaree A, ghorbian S. The Roles of Long non-coding RNAs (lncRNA) in Prostate Cancer . JABS 2019; 9 (1) :1187-1199
URL: http://jabs.fums.ac.ir/article-1-1805-en.html
1- Departman of Molecular Genetic, Ahar Branch, Islamic Azad University, Ahar, Iran
2- Departman of Molecular Genetic, Ahar Branch, Islamic Azad University, Ahar, Iran , ghorbian20@yahoo.com
Abstract:   (3989 Views)
Background & Objective: Prostate cancer is a compound condition in which gene expression has altered. Several surveys have revealed that genetic components have been involved in prostate cancer progression. Findings proposed that they can modify a noteworthy portion of disposing of elements, which is associated to the developing prostate cancer in protein coding sequences. The purpose of this research was to indicate that there are many long non-coding RNAs with over 200 nucleotides length found in the human genome, which showed a significant role in the pathogenesis of prostate cancer. 
Conclusion: The role of LncRNAs as tumor suppressors or oncogenes has been demonstrated in several types of cancers, including prostate cancer. Recent investigations have disclosed that LncRNAs transcripts play a pivotal role in the tumorigenesis.
 


 
Full-Text [PDF 1244 kb]   (3102 Downloads)    
Type of Study: Review | Subject: Oncology
Received: 2018/08/17 | Accepted: 2019/01/7 | Published: 2019/06/8

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Journal of Advanced Biomedical Sciences

Designed & Developed by: Yektaweb

Creative Commons License
This work is licensed under a Creative Commons — Attribution-NonCommercial 4.0 International (CC BY-NC 4.0)